| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7389632 | Value in Health Regional Issues | 2018 | 5 Pages |
Abstract
The drug policy in Romania is centered on price reduction using different techniques and no value-based criteria are used. The pricing is not included in the health technology assessment system, managed entry agreements are not used, and the main effect visible at the patient level is the lack of drugs for some therapeutic areas.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ciprian-Paul MD, PhD, Bogdan Cristian MD, PhD, Florentina Ligia MD, PhD,